Warnings & Disclaimers (Read First) Not for pregnant or nursing individuals, or anyone under 18
Multiple randomised, placebo-controlled trials have tested GLP-1 drugs as add-on therapy to insulin in people with T1D, and the picture that emerges is consistent, if modest: meaningful weight loss, real reductions in daily insulin needs, and improvements in CGM time in range
9b, quantification at the tumor: Fig
Theres probably 50 years of research, and theyve been available for 20 years longer than most people realize, says Rekha Kumar, MD, an endocrinologist and obesity medicine expert at Weill Cornell Medical College and NewYork-Presbyterian Hospital in New York City
Healthy, non-smoking adults between the ages of 18 to 50 years were recruited to participate in this study